$AVNR Recent News 6 stocks to watch 3:06 p.m. Nov. 5,

New Post Public Reply Private Reply Replies (0) Message Board

Nov 18, 2014 at 9:40 AM

$AVNR Recent News

6 stocks to watch 3:06 p.m. Nov. 5, 2014 - The Trading Deck
U.S. markets break out, confirm primary uptrend 11:12 a.m. Nov. 3, 2014 - Michael Ashbaugh
6 stocks to watch 2:10 p.m. Oct. 22, 2014 - The Trading Deck
5 stocks to watch 1:37 p.m. Sept. 24, 2014 - The Trading Deck
4 stocks to watch 2:47 p.m. Sept. 18, 2014 - The Trading Deck
5 companies that will benefit from ALS awareness 6:58 a.m. Aug. 22, 2014 - Jennifer Booton
U.S. stock futures cut rise after retail sales 7:53 a.m. Aug. 13, 2013 - Barbara Kollmeyer
Cree, Flowers Foods in focus Tuesday 7:42 a.m. Aug. 13, 2013 - Wallace Witkowski
Yum Brands shares drop on sour China sales 4:23 p.m. Aug. 12, 2013 - Wallace Witkowski
Avanir to promote Merck's diabetes drug Januvia 3:48 p.m. Aug. 12, 2013 - MarketWatch.com
Avanir shares rise after hours on license deal 5:29 p.m. July 2, 2013 - Wallace Witkowski
Avanir, OptiNose enter N. America licensing deal 4:27 p.m. July 2, 2013 - MarketWatch.com
7 gut checks before the stock market's opening bell 5:43 a.m. April 29, 2013 - Shawn Langlois
Avanir Pharmaceuticals shares down 3% 9:37 a.m. Nov. 17, 2010 - Nick Godt
Monday’s biggest gaining and declining stocks 4:25 p.m. Nov. 1, 2010 - Laura Mandaro
Avanir and Allergan lead drug stocks 12:55 p.m. Nov. 1, 2010 - Val Brickates Kennedy
Avanir leads drug stocks north 9:06 a.m. Nov. 1, 2010 - Val Brickates Kennedy
Rexahn, Avanir gain; Sequenom falls 12:32 p.m. April 7, 2010 - Val Brickates Kennedy
Avanir, Opexa gain ahead of presentations 2:16 p.m. April 6, 2010 - Val Brickates Kennedy
Avanir shares jump 10% in pre-market action 8:27 a.m. April 6, 2010 - Val Brickates Kennedy

Avanir Faces Regulatory Setback, AVP-825 Could Be Delayed - Analyst Blog 5:40 p.m. Nov. 10, 2014 - Zacks.com
Avanir Pharmaceuticals (AVNR) Stock Drops After FDA Provides New Drug Application Feedback 11:25 a.m. Nov. 7, 2014 - TheStreet.com
Will Avanir Pharmaceuticals (AVNR) Stock React Today to This Analyst Action? 8:52 a.m. Nov. 4, 2014 - TheStreet.com
Looking For My Next Triple In Biotech 1:26 p.m. Oct. 31, 2014 - Seeking Alpha
Perilous Reversal Stock: AVANIR Pharmaceuticals (AVNR) 10:19 a.m. Oct. 31, 2014 - TheStreet.com
Avanir Pharmaceuticals, Inc. (AVNR): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. Oct. 31, 2014 - Zacks.com
Trade-Ideas: AVANIR Pharmaceuticals (AVNR) Is Today's Post-Market Leader Stock 4:19 p.m. Oct. 30, 2014 - TheStreet.com
5 Stocks That Will See Huge Buying Friday on Russell 2000 Rebalance 7:48 a.m. Oct. 30, 2014 - 247WallSt.com
Hottest Healthcare Stocks Now – APTO AVNR CNC XRAY 8:45 a.m. Oct. 29, 2014 - InvestorPlace.com
Hottest Healthcare Stocks Now – LCI AVNR MWIV ABC 8:00 a.m. Oct. 27, 2014 - InvestorPlace.com
Genervon ALS drug shows encouraging results 8:27 a.m. Oct. 20, 2014 - Seeking Alpha
Biotech Stock Mailbag: Small-Cap Rebound, Avanir, Ohr, CytoSorbents 7:05 a.m. Oct. 17, 2014 - TheStreet.com
Intra-Cellular Therapies Reveals Top-line Data on ITI-007 - Analyst Blog 5:50 p.m. Oct. 16, 2014 - Zacks.com
Concert Pharmaceuticals Announces Positive CTP-354 Data - Analyst Blog 6:04 p.m. Oct. 15, 2014 - Zacks.com
Avanir (AVNR) Presents Detailed Phase II Data on AVP-923 - Analyst Blog 5:30 p.m. Oct. 14, 2014 - Zacks.com
Avanir presents AVP-923 Phase 2 data at neurology meeting 5:34 p.m. Oct. 13, 2014 - Seeking Alpha
Micro-Cap ETF And The Falling Greenback 4:28 p.m. Oct. 13, 2014 - Benzinga.com
Trade-Ideas: AVANIR Pharmaceuticals (AVNR) Is Today's Post-Market Leader Stock 4:17 p.m. Oct. 13, 2014 - TheStreet.com
Hottest Healthcare Stocks Now – ALNY VRTX AZN ANAC 9:15 a.m. Oct. 13, 2014 - InvestorPlace.com
Virobay on deck for IPO 9:54 a.m. Oct. 7, 2014 - Seeking Alpha

Avanir Pharmaceuticals Announces Preliminary Feedback from the FDA on AVP-825 for the Acute Treatment of Migraine 8:30 a.m. Nov. 7, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Publication of Pivotal Phase III Results from AVP-825 Acute Migraine Study in the Journal "Headache" 3:01 p.m. Oct. 30, 2014 - PR Newswire - PRF
Pharma Stocks Technical Data - Allergan, Zoetis, Actavis, Avanir Pharma, and Mallinckrodt 7:40 a.m. Oct. 20, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals to Host Investor Briefing on October 15, 2014 3:15 p.m. Oct. 8, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Data Presentations at the American Neurological Association's (ANA) 2014 Annual Meeting Including Results from the Phase II Trial for Treatment of Agitation in Patients with Alzheimer's Disease 7:30 a.m. Oct. 8, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares 8:15 a.m. Sept. 29, 2014 - PR Newswire - PRF
Acquisitions, Senior Level Promotions, Public Offering, and Drug Approvals - Research Reports on Acorda, Alexion, Envision, Lilly and Avanir 7:50 a.m. Sept. 29, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Pricing of Public Offering of Common Stock 9:00 p.m. Sept. 23, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Proposed Public Offering of Common Stock 3:45 p.m. Sept. 22, 2014 - PR Newswire - PRF
Positive Study Results, Market Activity, Acquisition Proposal, Earnings Schedules, and Collaboration - Research Reports on Avanir, Jazz, Alere, Intuitive Surgical and GSK 8:05 a.m. Sept. 18, 2014 - PR Newswire - PRF
Critical Alerts For Yahoo!, El Pollo Loco, Avanir Pharmaceuticals, General Electric and Ballard Power Systems Released By InvestorsObserver 8:31 a.m. Sept. 16, 2014 - PR Newswire - PRF
Reveal Insider Trading for Yahoo, Apple, Facebook, Avanir Pharmaceuticals, Tesla Motors, and Twitter 7:55 a.m. Sept. 16, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Positive Phase II Trial Results for AVP-923 in Treatment of Agitation in Patients with Alzheimer's Disease 7:30 a.m. Sept. 15, 2014 - PR Newswire - PRF
Technical Snapshot on Pharma Stocks - Allergan, Akorn, Mallinckrodt, Mylan, and AVANIR Pharma 8:25 a.m. Sept. 8, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference 8:00 a.m. Sept. 2, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 8:00 a.m. Aug. 26, 2014 - PR Newswire - PRF
Technical Analysis on Pharma Equities -- Mylan, AVANIR Pharma, Horizon Pharma, VIVUS, and Auxilium Pharma 8:10 a.m. Aug. 6, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Reports Fiscal 2014 Third Quarter Financial and Business Update 3:01 p.m. Aug. 5, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Date of Fiscal 2014 Third Quarter Financial Results and Conference Call 7:31 a.m. July 28, 2014 - GlobeNewswire
Avanir Pharmaceuticals Announces FDA Acceptance of IND for AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 8:15 a.m. July 21, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Plan A Bets on AI in High-Stakes M&A Arena

Digging Deeper with AI in M&A Deals Picture this: you’re at the table with a fat corporate M&A deal, eyes darting as you decipher numbers and nods, when out swings Plan A Technologies with their new ace up their sleeve—a stealth AI assessment tool armed to sharpen their technical due diligence. Unmasking the Tech Jigsaw Las Vegas-based Plan A Technologies hasn't just...

Acer's New Monitors: ePaper, Triple Displays & More

Next-Gen Screens: Breakthrough or Bust? So, Acer’s stepping up its game, unveiling an armory of gadgets designed to cement their spot in the tech arena. On the menu today? ePaper displays and enhanced connectivity gizmos that could either tip the scales or sink like a stone. Keep your eyes peeled, though—these updates aren't just another throwaway press release....

UNISORB Expands Reach with BILZ Acquisition

UNISORB Acquisition: A Game-Changer for Industrial Solutions This ain't the first time a company took over another to expand its footprint, but UNISORB's latest move to scoop up BILZ-USA is worth a closer look. Everybody's talking about this takeover that throws UNISORB right into the spotlight of North America's industrial sector. Naming them the exclusive distributor of...

Tradr's Bold Venture: Anthropic ETFs Ahead of IPO

Why Tradr Is Diving Into Anthropic's Hype There's a whiff of anticipation in the air as Anthropic gears up for its much-anticipated IPO, and Tradr isn't sitting on its hands here. They've just filed for two ETFs—one long, one short—ahead of the big day. We're talking about ANTT and ANTZ, betting on leveraged and inverse plays on whatever whirlwind Anthropic's stock...

York Urged to Retire Research Macaques After Probe

Undercover Investigation Shakes Up York University If you thought the world of research was all about sterile labs and the pursuit of knowledge, think again. The Jane Goodall Institute (JGI), famed for championing animal welfare, has urged York University to let go of nine long-suffering rhesus macaques. Turns out, these macaques weren't exactly living their best lives....

Early Education's Massive Impact: Key Skills for Success

Unlocking Lifelong Success: The Early Advantage Ever look at a successful adult and wonder, "Where'd they get that spark?" According to HelloNation and child care expert Karen Ego, it all starts early. Think of early learning not just as prepping for school, but as the first blueprint for life's journey. It's the skills you pick up in those tender years that stick it out...

Backroads Sets 2027 Egypt Tour with Active Adventures

Backroads Brings Adventure Travel to Egypt in 2027 There's an entirely fresh way to get your kicks by the pyramids, and it's coming straight from Backroads, the bigwig of active travel. They're rolling out a Multi-Adventure Tour in the heart of Egypt for 2027. It's got all the bells and whistles: hiking, biking, and kayaking, packaged with a side of luxury at posh hotels...

Texas Institute Leads Trailblazing Arrhythmia Study

Breaking New Ground in Heart Rhythm Treatment Well, here's a twist that even the stock market folks might envy—pioneering innovation in healthcare. This time, it’s not about tech stocks or a bull market, but about real human lives. The Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center in Austin has jumped to the forefront by participating in a...

Evotec and Plectonic Join Forces on Tumor Immunotherapy

Collaboration Spotlight: A New Horizon for Tumor Treatments Ever wonder why curing solid tumors has been such a tough nut to crack? Evotec SE (NASDAQ: EVO) and Plectonic Biotech are wagering that their collaboration might just hold the key to unlocking new answers. They’re pooling their cutting-edge tech to take a fresh swing at this stubborn problem. Here’s what’s...

Codoxo Snags 2026 Award for AI Payment Innovation

Revolutionizing Healthcare Payment with AI Ah, healthcare and payments—two things that can make even the most patient folks lose their cool. But here comes Codoxo, shaking up this landscape with its Point Zero Payment Integrity solution, and someone's finally giving them the nod they deserve. For those of us who have been in the game for a while, this announcement is...